Logo
x

Search

Subscribe Now

EU approval

Insights+: EMA Marketing Authorization of New Drugs in April 2024

Insights+: EMA Marketing Authorization of New Drugs in April 2024

  • May 21, 2024
Insights+: EMA Marketing Authorization of New Drugs in March 2024

Insights+: EMA Marketing Authorization of New Drugs in March 2024

  • April 22, 2024
Insights+: EMA Marketing Authorization of New Drugs in February 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2024

  • March 20, 2024
Insights+: EMA Marketing Authorization of New Drugs in January 2024

Insights+: EMA Marketing Authorization of New Drugs in January 2024

  • February 21, 2024
UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures

UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures

  • October 23, 2020
Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease

Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease

  • November 26, 2018
Roche

    Roche's Tecentriq (atezolizumab) + Avastin (bevacizumab) Receive the EC's Approval for Unresectable Hepatocellular Carcinoma

    • November 3, 2020
    UCB

      UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures

      • October 23, 2020
      Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease

        Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease

        • November 26, 2018
        Mundipharma Receives EU Approval for Pelmeg (Pegfilgrastim- Biosimilar)

          Mundipharma Receives EU Approval for Pelmeg (Pegfilgrastim- Biosimilar)

          • November 24, 2018
          Novartis Receives EU Approval for Cosentyx

            Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA)

            • October 26, 2018
            Merck

              Merck's (KEYTRUDA in combination with ALIMTA and Pt CT) Receives EU Approval for 1L mNonsq NSCLC with no EGFR or ALK Genomic Tumou...

              • September 10, 2018
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.